NO861963L - Retrovirale polypeptider knyttet til menneskecelleomdannelse. - Google Patents

Retrovirale polypeptider knyttet til menneskecelleomdannelse.

Info

Publication number
NO861963L
NO861963L NO861963A NO861963A NO861963L NO 861963 L NO861963 L NO 861963L NO 861963 A NO861963 A NO 861963A NO 861963 A NO861963 A NO 861963A NO 861963 L NO861963 L NO 861963L
Authority
NO
Norway
Prior art keywords
cell
pct
reversion
human
polypeptides related
Prior art date
Application number
NO861963A
Other languages
English (en)
Norwegian (no)
Inventor
Dennis D Slamon
Irvin S Y Chen
Martin J Cline
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO861963L publication Critical patent/NO861963L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO861963A 1984-09-19 1986-05-16 Retrovirale polypeptider knyttet til menneskecelleomdannelse. NO861963L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65277584A 1984-09-19 1984-09-19

Publications (1)

Publication Number Publication Date
NO861963L true NO861963L (no) 1986-05-16

Family

ID=24618109

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861963A NO861963L (no) 1984-09-19 1986-05-16 Retrovirale polypeptider knyttet til menneskecelleomdannelse.

Country Status (9)

Country Link
US (1) US5063150A (de)
EP (1) EP0196319B1 (de)
JP (2) JPS62500452A (de)
AT (1) ATE71150T1 (de)
AU (1) AU600224B2 (de)
DE (1) DE3585087D1 (de)
DK (1) DK228486A (de)
NO (1) NO861963L (de)
WO (1) WO1986001834A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008182A (en) * 1986-01-10 1991-04-16 Cetus Corporation Detection of AIDS associated virus by polymerase chain reaction
US5176995A (en) * 1985-03-28 1993-01-05 Hoffmann-La Roche Inc. Detection of viruses by amplification and hybridization
AU606043B2 (en) 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
US5364933A (en) * 1986-03-03 1994-11-15 Institut Pasteur Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US6514691B1 (en) 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
US4753873A (en) * 1986-02-03 1988-06-28 Cambridge Bioscience Corporation Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
US5681696A (en) * 1987-01-09 1997-10-28 United Biomedical, Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV
US5476765A (en) * 1987-01-09 1995-12-19 United Biomedical, Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV and as vaccines
US4833071A (en) * 1987-01-09 1989-05-23 United Biomedical, Inc. Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
WO1990004020A1 (en) * 1988-10-06 1990-04-19 Dana Farber Cancer Institute H. saimiri-htlv-x region vector
JPH02186266A (ja) * 1988-10-14 1990-07-20 Eisai Co Ltd 経母乳感染の測定方法および試薬
EP0404935B1 (de) * 1989-01-13 1995-01-04 United Biomedical Inc. Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1
SE8900721D0 (sv) 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
IL95738A (en) * 1989-09-23 1996-11-14 Hoechst Ag Antibodies against the well-preserved amino acid sequences of insulin, a process for their preparation and use in immunoassay
JP2807287B2 (ja) * 1989-10-13 1998-10-08 株式会社医学生物学研究所 ペプチドおよびその用途
US5292658A (en) * 1989-12-29 1994-03-08 University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center Cloning and expressions of Renilla luciferase
CA2094832A1 (en) * 1990-10-26 1992-04-27 Myron E. Essex Specific detection of antibodies to human t-cell leukemia viruses
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
JP3506252B2 (ja) * 1992-02-24 2004-03-15 ジェネラブス・テクノロジーズ・インコーポレイテッド Ｈｔｌｖ−ｉ／ｈｔｌｖ−ｉｉの分析及び方法
US6406841B1 (en) 1993-07-01 2002-06-18 Abbott Laboratories Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
JP5999703B2 (ja) * 2013-01-09 2016-09-28 国立大学法人 東京医科歯科大学 ＨＬＡ−ＤＲ１拘束性Ｔａｘ特異的ＣＤ４＋Ｔ細胞エピトープ

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
JPS56163456A (en) * 1980-05-21 1981-12-16 Otsuka Pharmaceut Co Ltd Preparation of antigen
US4311639A (en) * 1980-07-25 1982-01-19 E. I. Du Pont De Nemours And Company Immunogenic interferon peptides
US4341761A (en) * 1980-07-25 1982-07-27 E. I. Du Pont De Nemours And Company Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
US4438030A (en) * 1980-07-25 1984-03-20 E. I. Du Pont De Nemours And Company Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
US4423034A (en) * 1980-10-16 1983-12-27 Toyo Jozo Kabushiki Kaisha Process for the preparation of antibodies
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
NZ213823A (en) * 1984-10-26 1988-05-30 Us Health Producing human t-cell leukemia retrovirus envelope protein fragments in bacteria

Also Published As

Publication number Publication date
EP0196319A1 (de) 1986-10-08
DK228486D0 (da) 1986-05-16
ATE71150T1 (de) 1992-01-15
EP0196319B1 (de) 1992-01-02
DK228486A (da) 1986-05-16
DE3585087D1 (de) 1992-02-13
AU4866285A (en) 1986-04-08
US5063150A (en) 1991-11-05
WO1986001834A1 (en) 1986-03-27
JPS62500452A (ja) 1987-02-26
JPS6446651A (en) 1989-02-21
AU600224B2 (en) 1990-08-09
EP0196319A4 (de) 1989-08-29

Similar Documents

Publication Publication Date Title
NO861963L (no) Retrovirale polypeptider knyttet til menneskecelleomdannelse.
ATE112687T1 (de) Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen.
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
DE68925226D1 (de) Monoklonale Antikörper
DE59010913D1 (de) Toxoplasma gondii-Antigene, ihre Herstellung und ihre Verwendung
DK169986D0 (da) Antigen beslaegtet med glycoproteinet i aids-virus, isaer en praekursor for glycoproteinet, og fremgangsmaade til fremstilling af et saadant antigen
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
DK201590A (da) Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse
IL61361A (en) N-aryl-n'-imidazol-2-ylureas,their preparation and pharmaceutical compositions containing them
DK462887A (da) Forbedrede bestemmelser af myasthenia gravis og substrater og saet til anvendelse derved.
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
ATE139259T1 (de) Selbstantigen der primären lebercirrhose
ATE40216T1 (de) Monoklonaler antikoerper.
DK528279A (da) Fremgangsmaade til isolering af hepatitis b e antigen eller antistof
TR199800575T1 (en) Kemokin �-8'in k�sa formlar�.
IT8026986A0 (it) Antigene di prostata umana purificato e procedimento per preparare anticorpi correlati a tale antigene.
DE69026812D1 (de) Konjugate von "pokeweed" antiviralem protein und monoklonalen antikörpern
DE3889945D1 (de) Methoden und Materialien für die HIV-Erkennung und Therapie.
ATE245661T1 (de) Natürliche menschliche igm antikörper
ES2059539T3 (es) Metodo para la prevencion de la enfermedad del injerto frente al huesped.
DK116487D0 (da) Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.
SU682790A1 (ru) Пробоотборник пульпы из пульпопровода
JPS6434371A (en) Periosteal bone forming material
SE8305667L (sv) Adenokarcinomrelaterade nya antigena determinanter och antikroppar som er specifika for dessa, forfarande for deras framstellning samt reagenssystem henforande sig till dem
ES2155436T3 (es) Proteinas recombinantes con la reactividad inmunologica del antigeno e del virus de la hepatitis b (hbeag), procedimiento para su preparacion y su utilizacion en analisis inmunologicos y en vacunas.